H1B Report
Side-by-side comparison

APTAPHARMA, INC vs INFOSYS LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
APTAPHARMA, INC
NJRank #FEIN 20-4970367
Entity B
INFOSYS LIMITED
TXRank #1FEIN 58-1760235

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAPTAPHARMA, INCINFOSYS LIMITED
Total filings48205,263
Certified %87.50%99.55%
Denied %6.25%0.21%
Withdrawn %4.17%0.20%
Cert-withdrawn %2.08%0.05%
Rank#1
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJTX

Outcomes — APTAPHARMA, INC

DOL case-status mix.

Outcome breakdown: Certified 87.5%, Cert-withdrawn 2.1%, Withdrawn 4.2%, Denied 6.3%
Outcome breakdown
OutcomeShare
Certified87.5%
Cert-withdrawn2.1%
Withdrawn4.2%
Denied6.3%
Certified87.5%
Cert-withdrawn2.1%
Withdrawn4.2%
Denied6.3%

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

APTAPHARMA, INC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104
FY20111
FY20120
FY20134
FY20142
FY20153
FY20169
FY20175
FY20184
FY20197
FY20200
FY20210
FY20220
FY20231
FY20242
FY20255
FY20261
INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558

Top 5 occupations — APTAPHARMA, INC

Top 5 occupations — INFOSYS LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.
Or browse the full sponsor index.